A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...
Researchers recently presented data on the secondary endpoints of STEMI-DTU (ST-segment Elevation Myocardial Infarction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results